Intraocular lens implantation device
Latest Santen Pharmaceutical Co., Ltd. Patents:
- Medicament comprising combination of sepetaprost and Rho-associated coiled-coil containing protein kinase inhibitor
- AGENT FOR TREATING OR PREVENTING GLAUCOMA INCLUDING A SULFONAMIDE COMPOUND AND ANOTHER DRUG
- Medicament for preventing and/or treating dry eye
- Agent for treating or preventing glaucoma including a sulfonamide compound and another drug
- Therapeutic agent for meibomian dysfunction
The dot-dot broken lines are directed to illustrative environmental subject matter that forms no part of the claimed design or to portions of the devices that form no part of the claimed design. The dash-dot broken lines represent bounds of the claimed design and do not themselves form a part of the claimed design.
Claims
The ornamental design for an intraocular lens implantation device, as shown and described.
5873879 | February 23, 1999 | Figueroa et al. |
6312433 | November 6, 2001 | Butts et al. |
6371960 | April 16, 2002 | Heyman et al. |
6923815 | August 2, 2005 | Brady et al. |
D645958 | September 27, 2011 | Assmann et al. |
8273122 | September 25, 2012 | Anderson |
8435289 | May 7, 2013 | Cole et al. |
D700321 | February 25, 2014 | Strong |
20030139809 | July 24, 2003 | Worst et al. |
20040199173 | October 7, 2004 | Meyer |
20040243141 | December 2, 2004 | Brown et al. |
20070050023 | March 1, 2007 | Bessiere et al. |
20120221102 | August 30, 2012 | Tanaka et al. |
20140135784 | May 15, 2014 | Maroscheck et al. |
20140200588 | July 17, 2014 | Anderson et al. |
20140257317 | September 11, 2014 | Safabash |
Type: Grant
Filed: Apr 29, 2013
Date of Patent: Sep 15, 2015
Assignee: Santen Pharmaceutical Co., Ltd. (Osaka-shi, Osaka)
Inventors: Christian Winfried Wargner (Osaka), Yoshitaka Yamada (Osaka), Katsuyuki Ueno (Osaka)
Primary Examiner: Garth Rademaker
Assistant Examiner: Samantha Q Lawrence
Application Number: 29/442,736